Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeOnc Technologies Holdings, Inc. - Common Stock (NQ:NTHI)

3.300 -0.270 (-7.56%)
Streaming Delayed Price Updated: 12:33 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 63,093
Open 3.530
Bid (Size) 3.260 (1)
Ask (Size) 3.440 (2)
Prev. Close 3.570
Today's Range 3.292 - 3.530
52wk Range 3.500 - 25.00
Shares Outstanding 19,026,776
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire

Performance

YTD
-72.7%
-72.7%
1 Month
-55.3%
-55.3%
3 Month
-75.3%
-75.3%
6 Month
-72.7%
-72.7%
1 Year
-72.7%
-72.7%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company’s New President
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Robinhood, Couchbase And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Topics Stocks
NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Why Xos Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is NeOnc Technologies Holdings, Inc. - Common Stock publicly traded?
Yes, NeOnc Technologies Holdings, Inc. - Common Stock is publicly traded.
What exchange does NeOnc Technologies Holdings, Inc. - Common Stock trade on?
NeOnc Technologies Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock?
The ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock is NTHI on the Nasdaq Stock Market
What is the current price of NeOnc Technologies Holdings, Inc. - Common Stock?
The current price of NeOnc Technologies Holdings, Inc. - Common Stock is 3.300
When was NeOnc Technologies Holdings, Inc. - Common Stock last traded?
The last trade of NeOnc Technologies Holdings, Inc. - Common Stock was at 07/01/25 12:33 PM ET
What is the market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock?
The market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock is 62.79M
How many shares of NeOnc Technologies Holdings, Inc. - Common Stock are outstanding?
NeOnc Technologies Holdings, Inc. - Common Stock has 63M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.